Family Heart Attack History Often Underreported, Study Reveals

By VirentaNews Staff — May 21, 2026

Family history of heart attacks is a well-established risk factor for cardiovascular disease, yet a new study from Karolinska Institutet shows that individuals frequently underreport such events among close relatives. Comparing self-reports with nationwide health registry data in Sweden, researchers found only moderate agreement, indicating that clinical assessments relying on patient-provided family histories may be systematically flawed. This underreporting is most pronounced when heart attacks occurred at younger ages, suggesting that incomplete information could lead to missed opportunities for early prevention and intervention in high-risk individuals.

Discrepancies Revealed in Self-Reported vs. Registry Data

The study, published in the European Journal of Epidemiology, analyzed data from 29,435 individuals participating in the Swedish Twin Registry who reported whether their parents or siblings had suffered heart attacks. These self-reports were then cross-referenced with Sweden’s comprehensive National Patient Register and Cause of Death Register, which capture hospitalizations and mortality due to myocardial infarction with high accuracy. The results showed that the overall agreement between self-reported and register-confirmed heart attacks among first-degree relatives was only moderate, with a kappa coefficient of 0.51—below the threshold typically considered substantial. Sensitivity, or the proportion of actual heart attacks correctly reported by participants, was 68% for fathers, 57% for mothers, and 64% for siblings. Notably, heart attacks occurring before age 50 were significantly more likely to go unreported, with sensitivity dropping to below 50% in some cases. These data suggest a systematic underestimation of familial cardiovascular risk when reliance is placed solely on patient recall.

Key Players: Researchers, Clinicians, and Public Health Agencies

The research was led by scientists at Karolinska Institutet’s Institute of Environmental Medicine, a leading center for epidemiological and public health research in Europe. The team leveraged Sweden’s uniquely detailed national health registries, which have been used for decades to track disease incidence and outcomes across populations with minimal loss to follow-up. Clinicians and preventive cardiologists are among the primary stakeholders affected by these findings, as family history remains a cornerstone of risk stratification tools such as the American Heart Association’s cardiovascular risk calculator and the European Society of Cardiology’s Systematic Coronary Risk Evaluation (SCORE) model. Public health agencies, including the World Health Organization, also incorporate family history into screening guidelines, particularly for individuals under 50 with no other traditional risk factors. The study underscores the need for these institutions to reconsider how familial risk is assessed, especially in primary care settings where electronic health records may not be linked to national registries.

Trade-Offs Between Accuracy and Practicality in Risk Assessment

While national health registries offer a more accurate picture of familial disease history, their use in clinical practice is limited by privacy regulations, data access restrictions, and logistical barriers. Self-reporting remains the default method in most healthcare systems due to its simplicity and low cost. However, this study highlights the trade-off between practicality and precision: relying on memory introduces recall bias, particularly for events that occurred decades ago or were not directly witnessed by the respondent. On the other hand, integrating registry data into routine care could improve risk prediction and enable earlier interventions, such as lipid-lowering therapy or lifestyle counseling, for genetically predisposed individuals. The ethical implications of accessing relatives’ health data without their consent must also be weighed, making widespread registry linkage a complex policy challenge. Nonetheless, for patients with a strong suspected genetic predisposition, targeted verification through medical records may be warranted.

Why Now? Rising Focus on Preventive Cardiology

The timing of this study aligns with a growing emphasis on preventive cardiology and precision public health. As cardiovascular disease remains the leading cause of death globally, responsible for nearly 18 million deaths annually according to the World Health Organization, identifying high-risk individuals before symptoms appear has become a priority. Advances in genetic testing and digital health records have made it feasible to move beyond self-reported data, yet many systems still operate on outdated assumptions about the reliability of patient histories. This research adds to a body of evidence showing that subjective reports of family health are often incomplete, particularly for stigmatized or poorly understood conditions. In the context of heart disease, where early intervention can significantly alter long-term outcomes, the findings underscore an urgent need to modernize risk assessment protocols.

Where We Go From Here

In the next 6 to 12 months, three scenarios could unfold. First, some healthcare systems—particularly in countries with centralized registries like Sweden, Denmark, and Estonia—may begin piloting programs that automatically verify family history against national databases during routine check-ups. Second, clinical guidelines could be revised to assign lower weight to self-reported family histories, especially when no other risk factors are present. Third, digital health tools, such as patient-facing apps that allow secure sharing of familial health data, might emerge as a middle ground between privacy and accuracy. Each path presents implementation challenges, but all point toward a future where risk assessment is less reliant on memory and more anchored in verified evidence.

Bottom line — improving the accuracy of familial heart attack history through registry linkage or digital verification could enhance early detection and prevention strategies, ultimately reducing the global burden of cardiovascular disease.

Source: MedicalXpress